Carrier-free (BSA/glycerol-free) EIF2AK2 mouse monoclonal antibody,clone OTI3F5
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) EIF2AK2 mouse monoclonal antibody,clone OTI3F5
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
EIF2AK2 mouse monoclonal antibody,clone OTI3F5
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
USD 509.00
2 Weeks
EIF2AK2 mouse monoclonal antibody,clone OTI3F5, Biotinylated
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Biotin |
USD 509.00
2 Weeks
EIF2AK2 mouse monoclonal antibody,clone OTI3F5, HRP conjugated
Applications | IHC, WB |
Reactivities | Human |
Conjugation | HRP |
EIF2AK2 mouse monoclonal antibody,clone OTI3F5
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
PKR (EIF2AK2) pThr451 rabbit polyclonal antibody, Aff - Purified
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Anti-EIF2AK2 Rabbit Polyclonal Antibody
Applications | IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | Synthetic peptide corresponding to a region derived from 438-451 amino acids of Human eukaryotic translation initiation factor 2-alpha kinase 2 |
PKR (EIF2AK2) rabbit polyclonal antibody, Aff - Purified
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Rabbit polyclonal PKR (Ab-451) antibody
Applications | IHC |
Reactivities | Human, Mouse |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human PKR around the phosphorylation site of threonine 451(K-G-TP-L-R). |
PKR (EIF2AK2) rabbit polyclonal antibody, Aff - Purified
Applications | IHC |
Reactivities | Human |
Conjugation | Unconjugated |
Rabbit polyclonal PKR (Thr451) antibody(Phospho-specific)
Applications | IHC |
Reactivities | Human, Mouse |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PKR around the phosphorylation site of threonine 451(K-G-TP-L-R). |
Modifications | Phospho-specific |